Filing Details

Accession Number:
0001854270-25-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-02-06 20:23:37
Reporting Period:
2025-02-04
Filing Date:
2025-02-06
Accepted Time:
2025-02-06 20:23:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1854270 Senti Biosciences Inc. SNTI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1852301 K Timothy Lu C/O Senti Biosciences, Inc.
2 Corporate Drive First Floor
South San Francisco CA 94080
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-02-04 3,922 $4.07 82,627 No 4 S Direct
Common Stock Disposition 2025-02-06 545 $4.36 82,082 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 52,839 Indirect By spouse
Common Stock 52,839 Indirect See footnote
Footnotes
  1. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
  2. The shares are held by Luminen Services, LLC, as trustee of the Luminen Trust, of which the reporting person is the settlor. The reporting person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.